Skip to content
English
Contact us
  • There are no suggestions because the search field is empty.

Clinical Validation

What Clinical Validation Does the CNSide® CSF TCE Test Have?

  • Publications   9+ peer-reviewed publications with several under review (as of January 2025).
  • Sensitivity   CNSide has shown a 92% sensitivity in detecting tumor cells in patients with LM. Source
  • Specificity   CNSide has shown a 95% specificity with no tumor cells detected in patients without LM. Source
  • Economic Value   A cost-of-care analysis abstract was recently published by The Professional Society for Health Economics and Outcomes Research (ISPOR). This abstract stated that "CNSide may reduce overall LM-related costs by ~40% (33%-47%), driven by earlier intervention, prolonged life expectancy, improved treatment precision, reduced adverse events and hospitalizations, and QALY gains." The full abstract can be found here.